🇺🇸 FDA
Pipeline program

GnRH-a-1M

2025012-5010

Unknown small_molecule active

Quick answer

GnRH-a-1M for Adenomyosis of Uterus is a Unknown program (small_molecule) at First Tracks Biotherapeutics with 1 ClinicalTrials.gov record(s).

Program details

Company
First Tracks Biotherapeutics
Indication
Adenomyosis of Uterus
Phase
Unknown
Modality
small_molecule
Status
active

Clinical trials